Does Medicaid pay too much for precscription drugs?: a case study of atypical anti-psychotics
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Cambridge, Mass.
National Bureau of Economic Research
2003
|
| Series: | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series
9626 |
| Subjects: | |
| Online Access: | Volltext |
| Physical Description: | 34, [15] S. |
Staff View
MARC
| LEADER | 00000nam a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV023590274 | ||
| 003 | DE-604 | ||
| 005 | 20090806 | ||
| 007 | t| | ||
| 008 | 021128s2003 xxu |||| 00||| eng d | ||
| 035 | |a (OCoLC)249017623 | ||
| 035 | |a (DE-599)BVBBV023590274 | ||
| 040 | |a DE-604 |b ger | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c XD-US | ||
| 049 | |a DE-521 | ||
| 084 | |a 15,3 |2 ssgn | ||
| 100 | 1 | |a Duggan, Mark G. |d 1970- |e Verfasser |0 (DE-588)129714402 |4 aut | |
| 245 | 1 | 0 | |a Does Medicaid pay too much for precscription drugs? |b a case study of atypical anti-psychotics |c Mark G. Duggan |
| 264 | 1 | |a Cambridge, Mass. |b National Bureau of Economic Research |c 2003 | |
| 300 | |a 34, [15] S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 9626 | |
| 648 | 4 | |a 1993-2001 | |
| 650 | 4 | |a Medicaid | |
| 650 | 4 | |a Verschreibungspflichtiges Arzneimittel | |
| 650 | 4 | |a Gesetzliche Krankenversicherung / Sozialhilfeempfänger / Pharmazeutisches Produkt / Psychopharmakon / Preis / Gesundheitskosten / Innovation / Produktivität / Gesundheit / Schätzung / Kalifornien / USA | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |
| 830 | 0 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 9626 |w (DE-604)BV002801238 |9 9626 | |
| 856 | 4 | 1 | |u http://papers.nber.org/papers/w9626.pdf |z kostenfrei |3 Volltext |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-016905604 | |
Record in the Search Index
| _version_ | 1831281909904179200 |
|---|---|
| adam_text | |
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Duggan, Mark G. 1970- |
| author_GND | (DE-588)129714402 |
| author_facet | Duggan, Mark G. 1970- |
| author_role | aut |
| author_sort | Duggan, Mark G. 1970- |
| author_variant | m g d mg mgd |
| building | Verbundindex |
| bvnumber | BV023590274 |
| ctrlnum | (OCoLC)249017623 (DE-599)BVBBV023590274 |
| era | 1993-2001 |
| era_facet | 1993-2001 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000zcb4500</leader><controlfield tag="001">BV023590274</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20090806</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">021128s2003 xxu |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)249017623</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV023590274</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">XD-US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-521</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Duggan, Mark G.</subfield><subfield code="d">1970-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)129714402</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Does Medicaid pay too much for precscription drugs?</subfield><subfield code="b">a case study of atypical anti-psychotics</subfield><subfield code="c">Mark G. Duggan</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, Mass.</subfield><subfield code="b">National Bureau of Economic Research</subfield><subfield code="c">2003</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">34, [15] S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">9626</subfield></datafield><datafield tag="648" ind1=" " ind2="4"><subfield code="a">1993-2001</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicaid</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Verschreibungspflichtiges Arzneimittel</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gesetzliche Krankenversicherung / Sozialhilfeempfänger / Pharmazeutisches Produkt / Psychopharmakon / Preis / Gesundheitskosten / Innovation / Produktivität / Gesundheit / Schätzung / Kalifornien / USA</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">9626</subfield><subfield code="w">(DE-604)BV002801238</subfield><subfield code="9">9626</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://papers.nber.org/papers/w9626.pdf</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016905604</subfield></datafield></record></collection> |
| id | DE-604.BV023590274 |
| illustrated | Not Illustrated |
| index_date | 2024-07-02T22:41:26Z |
| indexdate | 2025-05-05T12:02:03Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016905604 |
| oclc_num | 249017623 |
| open_access_boolean | 1 |
| owner | DE-521 |
| owner_facet | DE-521 |
| physical | 34, [15] S. |
| publishDate | 2003 |
| publishDateSearch | 2003 |
| publishDateSort | 2003 |
| publisher | National Bureau of Economic Research |
| record_format | marc |
| series | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
| series2 | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
| spelling | Duggan, Mark G. 1970- Verfasser (DE-588)129714402 aut Does Medicaid pay too much for precscription drugs? a case study of atypical anti-psychotics Mark G. Duggan Cambridge, Mass. National Bureau of Economic Research 2003 34, [15] S. txt rdacontent n rdamedia nc rdacarrier National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 9626 1993-2001 Medicaid Verschreibungspflichtiges Arzneimittel Gesetzliche Krankenversicherung / Sozialhilfeempfänger / Pharmazeutisches Produkt / Psychopharmakon / Preis / Gesundheitskosten / Innovation / Produktivität / Gesundheit / Schätzung / Kalifornien / USA Erscheint auch als Online-Ausgabe National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 9626 (DE-604)BV002801238 9626 http://papers.nber.org/papers/w9626.pdf kostenfrei Volltext |
| spellingShingle | Duggan, Mark G. 1970- Does Medicaid pay too much for precscription drugs? a case study of atypical anti-psychotics National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series Medicaid Verschreibungspflichtiges Arzneimittel Gesetzliche Krankenversicherung / Sozialhilfeempfänger / Pharmazeutisches Produkt / Psychopharmakon / Preis / Gesundheitskosten / Innovation / Produktivität / Gesundheit / Schätzung / Kalifornien / USA |
| title | Does Medicaid pay too much for precscription drugs? a case study of atypical anti-psychotics |
| title_auth | Does Medicaid pay too much for precscription drugs? a case study of atypical anti-psychotics |
| title_exact_search | Does Medicaid pay too much for precscription drugs? a case study of atypical anti-psychotics |
| title_exact_search_txtP | Does Medicaid pay too much for precscription drugs? a case study of atypical anti-psychotics |
| title_full | Does Medicaid pay too much for precscription drugs? a case study of atypical anti-psychotics Mark G. Duggan |
| title_fullStr | Does Medicaid pay too much for precscription drugs? a case study of atypical anti-psychotics Mark G. Duggan |
| title_full_unstemmed | Does Medicaid pay too much for precscription drugs? a case study of atypical anti-psychotics Mark G. Duggan |
| title_short | Does Medicaid pay too much for precscription drugs? |
| title_sort | does medicaid pay too much for precscription drugs a case study of atypical anti psychotics |
| title_sub | a case study of atypical anti-psychotics |
| topic | Medicaid Verschreibungspflichtiges Arzneimittel Gesetzliche Krankenversicherung / Sozialhilfeempfänger / Pharmazeutisches Produkt / Psychopharmakon / Preis / Gesundheitskosten / Innovation / Produktivität / Gesundheit / Schätzung / Kalifornien / USA |
| topic_facet | Medicaid Verschreibungspflichtiges Arzneimittel Gesetzliche Krankenversicherung / Sozialhilfeempfänger / Pharmazeutisches Produkt / Psychopharmakon / Preis / Gesundheitskosten / Innovation / Produktivität / Gesundheit / Schätzung / Kalifornien / USA |
| url | http://papers.nber.org/papers/w9626.pdf |
| volume_link | (DE-604)BV002801238 |
| work_keys_str_mv | AT dugganmarkg doesmedicaidpaytoomuchforprecscriptiondrugsacasestudyofatypicalantipsychotics |